Mass Spectrometry Imaging Maps Intact Proteins in Tissue - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Mass Spectrometry Imaging Maps Intact Proteins in Tissue

  • October 21, 2026

  • 3 min

Share

Clinical Scorecard: Mass Spectrometry Imaging Maps Intact Proteins in Tissue

At a Glance

CategoryDetail
ConditionSpatial distribution of intact proteins and proteoforms in biological tissue
Key MechanismsNano-DESI extracts molecules from the tissue surface through a liquid bridge for mass spectrometry imaging; intact masses and fragmentation patterns support proteoform identification.
Target PopulationFresh-frozen tissue sections studied in proteomics research; representative imaging was performed on mouse brain tissue.
Care SettingLaboratory-based tissue imaging and proteomics research

Key Highlights

  • The protocol maps intact protein forms at approximately 10-micrometer spatial resolution.
  • Ethanol and chloroform washes remove lipids; ethanol also precipitates proteins to help limit their movement during delipidation.
  • A shear-force probe maintains probe-to-tissue distance and helps stabilize the liquid bridge while avoiding surface contact.
  • Multiply charged protein ions are suitable for top-down tandem mass spectrometry, and proteoforms are identified using intact masses and fragmentation patterns.
  • Current experiments typically detect tens of proteoforms rather than the full tissue proteome, with most reported targets being abundant proteins smaller than 20 kilodaltons.

Guideline-Based Recommendations

Diagnosis

  • Identify proteoforms by comparing intact masses and fragmentation patterns with database records.

Management

  • Use the described workflow for research imaging of intact proteins in fresh-frozen tissue; the article does not describe clinical treatment.

Monitoring & Follow-up

  • The article does not provide clinical monitoring recommendations.

Risks

  • Higher spatial resolution reduces the material collected at each location and can weaken protein signals.
  • Thicker tissue sections may make the surface less uniform and increase the risk of blocking the small capillaries.

Patient & Prescribing Data

Not applicable; the article describes a laboratory method using biological tissue, including mouse brain tissue.

No patient prescribing or treatment data are reported.

Clinical Best Practices

  • Use ethanol and chloroform washes before imaging to remove lipids that can suppress protein signals.
  • Maintain a constant probe-to-tissue distance with a shear-force probe to stabilize sampling and avoid capillary contact with the tissue surface.
  • Consider targeted tandem mass spectrometry on an adjacent tissue section after imaging identifies regions of interest.
  • Account for sensitivity, ionization efficiency, spectral processing, and fragmentation as areas for further method improvement.

Related Resources & Content

    Original Source(s)

    Related Content